19 results on '"Cárdaba, Blanca"'
Search Results
2. Effect of Obesity on the Expression of Genes Associated with Severe Asthma—A Pilot Study.
- Author
-
Bantulà, Marina, Arismendi, Ebymar, Tubita, Valeria, Roca-Ferrer, Jordi, Mullol, Joaquim, de Hollanda, Ana, Sastre, Joaquín, Valero, Antonio, Baos, Selene, Cremades-Jimeno, Lucía, Cárdaba, Blanca, and Picado, César
- Subjects
GENE expression ,MONONUCLEAR leukocytes ,WHEEZE ,ASTHMATICS ,GENOTYPE-environment interaction ,ASTHMA - Abstract
Asthma is a complex condition resulting from the interaction of genes and environment. Obesity is a risk factor to develop asthma and contributes to poor response to asthma therapy and severity. The aim of the study was to evaluate the effect of obesity on the expression levels of genes previously associated with severe asthma. Three groups of subjects were studied: non-obese asthmatics (NOA), obese asthma patients (OA), and non-asthmatic obese subjects (O). Previously reported overexpressed (IL-10, MSR1, PHLDA1, SERPINB2, and CD86) and underexpressed genes (CHI3L1, CPA3, IL-8, and PI3) in severe asthma were analyzed by RT-qPCR in peripheral blood mononuclear cells (PBMCs). In the overexpressed genes, obesity significantly decreased the expression of MSR1 and PHLDA1 and had no effects on CD86, IL-10, and SERPINB2. In underexpressed genes, obesity did not affect PI3, CHI3L1, and IL-8 and significantly reduced CPA3 expression. The results of this study show that obesity should be included among the known factors that can contribute toward modifying the expression of genes associated with asthma and, in particular, severe asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels.
- Author
-
Agüero-Rabes, Pablo, Pérez-Pérez, Julián, Cremades-Jimeno, Lucía, García-Ayllón, María-Salud, Gea-González, Adriana, Sainz, María José, Mahillo-Fernández, Ignacio, Téllez, Raquel, Cárdaba, Blanca, Sáez-Valero, Javier, and Gómez-Tortosa, Estrella
- Subjects
GENETIC variation ,NONAGENARIANS ,CEREBROSPINAL fluid ,CEREBROSPINAL fluid examination ,AGE of onset - Abstract
ADAM10 is the main α-secretase acting in the non-amyloidogenic processing of APP. We hypothesized that certain rare ADAM10 variants could increase the risk for AD by conferring the age-related downregulation of α-secretase. The ADAM10 gene was sequenced in 103 AD cases (82% familial) and 96 cognitively preserved nonagenarians. We examined rare variants (MAF < 0.01) and determined their potential association in the AD group with lower CSF protein levels, as analyzed by means of ELISA, and Western blot (species of 50 kDa, 55 kDa, and 80 kDa). Rare variants were found in 15.5% of AD cases (23% early-onset, 8% late-onset) and in 12.5% of nonagenarians, and some were group-specific. All were intronic variants except Q170H, found in three AD cases and one nonagenarian. The 3′UTR rs74016945 (MAF = 0.01) was found in 6% of the nonagenarians (OR 0.146, p = 0.057). Altogether, ADAM10 total levels or specific species were not significantly different when comparing AD with controls or carriers of rare variants versus non-carriers (except a Q170H carrier exhibiting low levels of all species), and did not differ according to the age at onset or APOE genotype. We conclude that ADAM10 exonic variants are uncommon in AD cases, and the presence of rare intronic variants (more frequent in early-onset cases) is not associated with decreased protein levels in CSF. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. How reliably can algorithms identify eosinophilic asthma phenotypes using non‐invasive biomarkers?
- Author
-
Betancor, Diana, Olaguibel, José María, Rodrigo‐Muñoz, José Manuel, Arismendi, Ebymar, Barranco, Pilar, Barroso, Blanca, Bobolea, Irina, Cárdaba, Blanca, Cruz, María Jesús, Curto, Elena, Del Pozo, Victoria, González‐Barcala, Francisco‐Javier, Martínez‐Rivera, Carlos, Mullol, Joaquim, Muñoz, Xavier, Picado, Cesar, Plaza, Vicente, Quirce, Santiago, Rial, Manuel Jorge, and Soto, Lorena
- Subjects
SPUTUM examination ,PHENOTYPES ,EOSINOPHILIC granuloma ,EOSINOPHILIA ,ASTHMA ,NASAL polyps ,MEDICAL protocols ,BIOMARKERS - Abstract
Background and Aims: Asthma is a heterogeneous respiratory disease that encompasses different inflammatory and functional endophenotypes. Many non‐invasive biomarkers has been investigated to its pathobiology. Heany et al proposed a clinical algorithm that classifies severe asthmatic patients into likely‐eosinophilic phenotypes, based on accessible biomarkers: PBE, current treatment, FeNO, presence of nasal polyps (NP) and age of onset. Materials and Methods: We assessed the concordance between the algorithm proposed by Heany et al. with sputum examination, the gold standard, in 145 asthmatic patients of the MEGA cohort with varying grades of severity. Results: No correlation was found between both classifications 0.025 (CI = 0.013–0.037). Moreover, no relationship was found between sputum eosinophilia and peripheral blood eosinophilia count in the total studied population. Discussion and Conclusion: In conclusion, our results suggest that grouping the biomarkers proposed by Heany et al. are insufficient to diagnose eosinophilic phenotypes in asthmatic patients. Sputum analysis remains the gold standard to assess airway inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Prioritizing Molecular Biomarkers in Asthma and Respiratory Allergy Using Systems Biology.
- Author
-
Cremades-Jimeno, Lucía, de Pedro, María Ángeles, López-Ramos, María, Sastre, Joaquín, Mínguez, Pablo, Fernández, Ignacio Mahillo, Baos, Selene, and Cárdaba, Blanca
- Subjects
RESPIRATORY allergy ,SYSTEMS biology ,ARTIFICIAL neural networks ,BIOMARKERS ,ALLERGIES ,WHEEZE - Abstract
Highly prevalent respiratory diseases such as asthma and allergy remain a pressing health challenge. Currently, there is an unmet need for precise diagnostic tools capable of predicting the great heterogeneity of these illnesses. In a previous study of 94 asthma/respiratory allergy biomarker candidates, we defined a group of potential biomarkers to distinguish clinical phenotypes (i.e. nonallergic asthma, allergic asthma, respiratory allergy without asthma) and disease severity. Here, we analyze our experimental results using complex algorithmic approaches that establish holistic disease models (systems biology), combining these insights with information available in specialized databases developed worldwide. With this approach, we aim to prioritize the most relevant biomarkers according to their specificity and mechanistic implication with molecular motifs of the diseases. The Therapeutic Performance Mapping System (Anaxomics' TPMS technology) was used to generate one mathematical model per disease: allergic asthma (AA), non-allergic asthma (NA), and respiratory allergy (RA), defining specific molecular motifs for each. The relationship of our molecular biomarker candidates and each disease was analyzed by artificial neural networks (ANNs) scores. These analyses prioritized molecular biomarkers specific to the diseases and to particular molecular motifs. As a first step, molecular characterization of the pathophysiological processes of AA defined 16 molecular motifs: 2 specific for AA, 2 shared with RA, and 12 shared with NA. Mechanistic analysis showed 17 proteins that were strongly related to AA. Eleven proteins were associated with RA and 16 proteins with NA. Specificity analysis showed that 12 proteins were specific to AA, 7 were specific to RA, and 2 to NA. Finally, a triggering analysis revealed a relevant role for AKT1, STAT1, and MAPK13 in all three conditions and for TLR4 in asthmatic diseases (AA and NA). In conclusion, this study has enabled us to prioritize biomarkers depending on the functionality associated with each disease and with specific molecular motifs, which could improve the definition and usefulness of new molecular biomarkers. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. CSF ADAM10 levels in AD patients in relationship to ADAM10 gene variants.
- Author
-
Agüero, Pablo, Cremades‐Jimeno, Lucía, García‐Ayllón, María‐Salud, Gea‐González, Adriana, Sainz, María José, Téllez, Raquel, Cárdaba, Blanca, Sáez‐Valero, Javier, Pérez‐Pérez, Julián, and Gómez‐Tortosa, Estrella
- Published
- 2023
- Full Text
- View/download PDF
7. Discriminatory Molecular Biomarkers of Allergic and Nonallergic Asthma and Its Severity.
- Author
-
Baos, Selene, Calzada, David, Cremades-Jimeno, Lucía, de Pedro, MªÁngeles, Sastre, Joaquín, Picado, César, Quiralte, Joaquín, Florido, Fernando, Lahoz, Carlos, and Cárdaba, Blanca
- Subjects
ASTHMA treatment ,BIOMARKERS ,PHENOTYPES ,ALLERGIES ,GENE expression - Abstract
Asthma is a complex disease comprising various phenotypes and endotypes, all of which still need solid biomarkers for accurate classification. In a previous study, we defined specific genes related to asthma and respiratory allergy by studying the expression of 94 genes in a population composed of 4 groups of subjects: healthy control, nonallergic asthmatic, asthmatic allergic, and nonasthmatic allergic patients. An analysis of differential gene expression between controls and patients revealed a set of statistically relevant genes mainly associated with disease severity, i.e., CHI3L1, IL-8, IL-10, MSR1, PHLDA1, PI3 , and SERPINB2. Here, we analyzed whether these genes and their proteins could be potential asthma biomarkers to distinguish between nonallergic asthmatic and asthmatic allergic subjects. Protein quantification was determined by ELISA (in serum) or Western blot (in protein extracted from peripheral blood mononuclear cells or PBMCs). Statistical analyses were performed by unpaired t -test using the Graph-Pad program. The sensitivity and specificity of the gene and protein expression of several candidate biomarkers in differentiating the two groups (and the severity subgroups) was performed by receiver operating characteristic (ROC) curve analysis using the R program. The ROC curve analysis determined single genes with good sensitivity and specificity for discriminating some of the phenotypes. However, interesting combinations of two or three protein biomarkers were found to distinguish the asthma disease and disease severity between the different phenotypes of this pathology using reproducible techniques in easy-to-obtain samples. Gene and protein panels formed by single biomarkers and biomarker combinations have been defined in easily obtainable samples and by standardized techniques. These panels could be useful for characterizing phenotypes of asthma, specifically when differentiating asthma severity. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. Polymorphisms of Tumor Necrosis Factor-α, Transforming Growth Factor-β, and Interleukin-10 in Asthma Associated with Olive Pollen Sensitization.
- Author
-
Cárdaba, Blanca, Calzada, David, Baos, Selene, Aguerri, Miriam, Quiralte, Joaquín, and Lahoz, Carlos
- Subjects
TUMOR necrosis factors ,EXPIRATORY flow ,SINGLE nucleotide polymorphisms ,KIDNEY diseases ,MULTIPLE sclerosis - Abstract
Sensitization to specific olive pollen-allergens (Ole e 2 and 10) has been correlated with a clinical pattern of asthma. This study analyzes the association between several polymorphims of TNFA (G-308A, C-857T, and C-1031T), IL10 (C-571A and A-1117G), and TGFB (C-509-T) and these sensitizations. These polymorphisms were genotyped by allelic discrimination, in olive pollen-allergic patients (phenotyped for specific Ole e 2 and 10 sensitizations) and healthy controls. Levels of serum-soluble cytokines were correlated with specific genotypes and clinical phenotypes. The results showed that heterozygous TGFB C-509T genotype, besides having the lowest sera TGF-levels, was significantly increased in olive pollen-allergic patients compared with controls. According specific sensitizations, CC genotype of IL10 C-571A could be a protective factor for Ole e 2 sensitization and mainly for asthmatic Ole e 2 sensitized patients compared with asthmatic non-Ole e 2 sensitized patients (OR: 0.26, P = 0.008). In contrast, heterozygous CA genotype was increased in Ole e 2 asthmatic subjects compared to asthmatic non-Ole e 2 sensitized patients. Lastly, heterozygous TNFA G-308A genotype was associated with Ole e 10 sensitization (OR: 2.5, P = 0.04). In conclusion, these results suggest a role of TGF-β1 in olive-pollen sensitization and TNF-α and IL-10 genotypes in the asthma induced by specific olive-pollen allergens. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
9. Association of Immunological Cell Profiles with Specific Clinical Phenotypes of Scleroderma Disease.
- Author
-
López-Cacho, José Manuel, Gallardo, Soledad, Posada, Manuel, Aguerri, Miriam, Calzada, David, Mayayo, Teodoro, González-Rodríguez, María Luisa, Rabasco, Antonio María, Lahoz, Carlos, and Cárdaba, Blanca
- Abstract
This study aimed to search the correlation among immunological profiles and clinical phenotypes of scleroderma in well characterized groups of scleroderma patients, comparing forty-nine scleroderma patients stratified according to specific clinical phenotypes with forty-nine healthy controls. Five immunological cell subpopulations (B, CD4
+ and CD8+ T-cells, NK, and monocytes) and their respective stages of apoptosis and activation were analyzed by flow cytometry, in samples of peripheral blood mononuclear cells (PBMCs). Analyses of results were stratified according to disease stage, time since the diagnosis, and visceral damage (pulmonary fibrosis, pulmonary hypertension, and cardiac affliction) and by time of treatment with corticosteroids. An increase in the percentages of monocytes and a decrease in the B cells were mainly related to the disease progression. A general apoptosis decrease was found in all phenotypes studied, except in localized scleroderma. An increase of B and NK cells activation was found in patients diagnosed more than 10 years ago. Specific cell populations like monocytes, NK, and B cells were associated with the type of affected organ. This study shows how, in a heterogeneous disease, proper patient's stratification according to clinical phenotypes allows finding specific cellular profiles. Our data may lead to improvements in the knowledge of prognosis factors and to aid in the analysis of future specific therapies. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
10. Expression of Macrophage Scavenger Receptor (MSR1) in Peripheral Blood Cells from Patients with Different Respiratory Diseases: Beyond Monocytes.
- Author
-
Baos, Selene, Cremades-Jimeno, Lucía, López-Ramos, María, de Pedro, María Ángeles, Uriarte, Silvia A., Sastre, Joaquín, González-Mangado, Nicolás, Rodríguez-Nieto, María Jesús, Peces-Barba, Germán, and Cárdaba, Blanca
- Subjects
BLOOD cells ,MONONUCLEAR leukocytes ,RESPIRATORY diseases ,MONOCYTES ,CHRONIC obstructive pulmonary disease - Abstract
Background: Macrophage scavenger receptor 1 (MSR1) has mostly been described in macrophages, but we previously found a significant gene expression increase in peripheral blood mononuclear cells (PBMCs) of asthmatic patients. Objective: To confirm those results and to define its cellular origin in PBMCs. Methods: Four groups of subjects were studied: healthy controls (C), nonallergic asthmatic (NA), allergic asthmatic (AA), and chronic obstructive pulmonary disease (COPD) patients. RNA was extracted from PBMCs. MSR1 gene expression was analyzed by RT-qPCR. The presence of MSR1 on the cellular surface of PBMC cellular subtypes was analyzed by confocal microscopy and flow cytometry. Results: MSR1 gene expression was significantly increased in the three clinical conditions compared to the healthy control group, with substantial variations according to disease type and severity. MSR1 expression on T cells (CD4
+ and CD8+ ), B cells, and monocytes was confirmed by confocal microscopy and flow cytometry. In all clinical groups, the four immune cell subtypes studied expressed MSR1, with a greater expression on B lymphocytes and monocytes, exhibiting differences according to disease and severity. Conclusions: This is the first description of MSR1's presence on lymphocytes' surfaces and reinforces the potential role of MSR1 as a player in asthma and COPD. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
11. Visual Hallucinations and HLA Class II Antigens in Cortical Dementia.
- Author
-
Gómez-Tortosa, Estrella, Aguerri, Miriam, Sainz, José M., Losada, Mireya, García-Ruiz, Pedro J., and Cárdaba, Blanca
- Subjects
PARKINSON'S disease diagnosis ,DEMENTIA ,HALLUCINATIONS ,RESEARCH methodology ,RESEARCH funding ,HLA-B27 antigen ,CLASSIFICATION - Abstract
Background: Visual hallucinations are a core feature of dementia with Lewy bodies (DLB) and have been proposed as being part of a narcolepsy-like REM sleep disorder. Selective loss of hypothalamic hypocretin-producing neurons is common to both narcolepsy and the spectrum of Lewy body diseases. We hypothesized that the genetic marker associated with narcolepsy, the HLA class II DR2-DQ6 haplotype, could confer some degree of susceptibility to brainstem-hypothalamic damage leading to the manifestation of visual hallucinations. Methods: We examined HLA class II haplotypes in 30 patients with prominent visual hallucinations in the context of clinical criteria for DLB and in 30 patients affected by a cortical-type dementia without hallucinations. Results: No significant differences were found in the distribution of DR and DQ antigens. Conclusions: We conclude that hypothalamic vulnerability in different diseases is not mediated by a common HLA haplotype. Copyright © 2010 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
12. Analysis of Polymorphisms in Olive Pollen Allergy: IL13, IL4RA, IL5 and ADRB2 Genes.
- Author
-
Llanes, Elena, Quiralte, Joaquín, López, Esther, Sastre, Beatriz, Chacártegui, Marina, del Pozo, Victoria, Palomino, Pilar, Lahoz, Carlos, and Cárdaba, Blanca
- Subjects
GENETIC polymorphisms ,INTERLEUKINS ,POLLEN ,ALLERGENS ,ASTHMA ,ALLERGIES ,POLYMERASE chain reaction - Abstract
Background: Previous results demonstrated that sensitization to specific olive pollen allergens could be related with a different clinical pattern (asthma and/or rhinitis), and that specific patterns of sensitization are regulated by different HLA class II antigens. The authors analyze the possible implication of 7 genetic polymorphisms described as asthma susceptibility genes: IL13 (C–1112T and R130Q), IL4RA (I50V, Q551R), IL5 (C–746T) and ADRB2 (Q27E and R16G) in specific olive pollen allergic sensitization. Methods: The authors genotyped seven polymorphisms of the IL13, IL4RA, IL5 and ADRB2 genes in 146 patients allergic to olive pollen with seasonal rhinitis/asthma and 50 controls using the polymerase chain reaction-restriction fragment length polymorphism and real-time polymerase chain reaction techniques. Results: Two polymorphisms of IL13 were associated with allergy to olive pollen: the TT genotype of IL13 C–1112T was decreased (odds ratio, OR = 0.35, p = 0.006) whereas the RQ heterozygous genotype of IL13 R130Q increased in patients allergic to olive pollen (OR = 3.12, p = 0.009). The combined analysis of two IL4RA single nucleotide polymorphisms (SNPs) (I50V and Q551R) showed an association with asthma: IL4RA V50/Q551 was associated with risk (OR = 2.48, p = 0.007) whereas the IL4RA V50R551 haplotype was associated with protection (OR = 0.31, p = 0.003). Conclusions: The IL13 polymorphisms under study were associated with specific allergy to olive pollen: the IL13 C–1112T polymorphism as a protective factor and the IL13 R130Q polymorphism as a risk factor. Interestingly, although single polymorphisms of IL4RA are not associated with any phenotype analyzed, the interaction between IL4RA I50V/Q551R was strongly associated with the asthma phenotype. IL13 and IL4RA could be relevant markers for allergy to olive pollen and asthma development. Copyright © 2008 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
13. Allergy to Dermatophagoides in a Group of Spanish Gypsies: Genetic Restrictions.
- Author
-
Cárdaba, Blanca, Moffatt, Miriam F., Fernández, Eduardo, Jurado, Aurora, Rojo, Marta, García, Milagros, Ansotegui, Ignacio J., Cortegano, Isabel, Arrieta, Ignacio, Etxenagusia, Miguel A., del Pozo, Victoria, Urraca, Javier, Aceituno, Esther, Gallardo, Soledad, Palomino, Pilar, Cookson, William, and Lahoz, Carlos
- Subjects
ALLERGIES ,DERMATOPHAGOIDES ,ROMANIES ,T cell receptors ,GENETIC polymorphisms - Abstract
Background: Spanish gypsies have traditionally lived as nomads, a reason why few epidemiological studies were done in this ethnic group. However, the high prevalence of asthmatic diseases demonstrated in a population residing in the North of Spain induces us to analyse whether it was due to the influence of genetic loci previously implicated in other population studies as causing the disorders. Methods: DRB1* and DQB1* HLA class II, TCR-Vα8.1, FcεRI-β Rsa I exon 7 and intron 2, TNF-β (LTα-Nco I) and CD14, were tested for association with asthma and atopy by multiple regression analysis, in 5 families comprising 87 individuals. Results: Significant associations were found with DQB1*02 (p = 0.02) and DQB1*0301 (p = 0.008) and elevated levels of total serum IgE. A negative association (p = 0.02) was found between total serum IgE and DRB1*14. FcεRI-β Rsa I-In2 allele 1 was associated with high levels of total serum IgE (p = 0.04). Levels of Der p 1 IgE antibodies were negatively associated with DRB1*11-DQB1*0301 (p = 0.007), and positively with TCR Vα-8 allele 1 (p = 0.04) and with FcεRI-β Rsa I-In2 allele 1 (p = 0.009). Conclusions: Our results do not show any association between asthma and the genetic loci studied although they do suggest the existence of multiple genetic influences on the allergic response in these families.Copyright © 2001 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
14. Interaction between galectin-3 and FcγRII induces down-regulation of IL-5 gene: implication of the promoter sequence IL-5REIII.
- Author
-
Cortegano, Isabel, Pozo, Victoria del, Cárdaba, Blanca, Arrieta, Ignacio, Gallardo, Soledad, Rojo, Marta, Aceituno, Esther, Takai, Toshiyuki, Verbeek, Sjef, Palomino, Pilar, Liu, Fu- Tong, and Lahoz, Carlos
- Abstract
Our previous work demonstrated the capacity of galectin-3 (a β-galactoside binding animal lectin) to inhibit IL-5 gene expression in different cell types, but the interaction of lectin with the cells and the pathways for the inhibition process are unknown. One of the purposes of this work was to study the cellular ligand for galectin-3. We have demonstrated that galectin-3 can bind to the low affinity IgG receptor (FcγRII or CD32) by using different experimental approaches, such as flow cytometry, fusion protein GST technology, and with a model of FcγRII-deficient mice. To further analyze the interaction between FcγRII and galectin-3, and its implication in IL-5 gene down-regulation we used FcγRII-deficient mice. When PBMC from these mice were incubated with galectin-3, the expression of the IL-5 gene was unchanged. However, when PBMC from wild type mice and FcγRIII-deficient mice were incubated with galectin-3, IL-5 gene expression was down-regulated. Finally, we studied the implication of the negative regulatory sequence in the IL-5 gene promoter. In the presence of galectin-3, a DNA-protein complex was formed with the IL-5REIII region. This complex was not observed when unrelated oligonucleotide was used. So, galectin-3 induces a pathway, which activates a transcription factor that binds to IL-5REIII. This interaction is capable of inhibiting IL-5 gene transcription. [ABSTRACT FROM PUBLISHER]
- Published
- 2000
- Full Text
- View/download PDF
15. Peptide Allergen Immunotherapy: A New Perspective in Olive-Pollen Allergy.
- Author
-
Calzada, David, Cremades-Jimeno, Lucía, López-Ramos, María, and Cárdaba, Blanca
- Subjects
PEPTIDOMIMETICS ,IMMUNOGLOBULIN E ,ALLERGIES ,IMMUNOTHERAPY ,INFLAMMATORY mediators ,RESPIRATORY diseases ,ALLERGENS ,POLLINATION - Abstract
Allergic diseases are highly prevalent disorders, mainly in industrialized countries where they constitute a high global health problem. Allergy is defined as an immune response "shifted toward a type 2 inflammation" induced by the interaction between the antigen (allergen) and IgE antibodies bound to mast cells and basophils that induce the release of inflammatory mediators that cause the clinical symptoms. Currently, allergen-specific immunotherapy (AIT) is the only treatment able to change the course of these diseases, modifying the type 2 inflammatory response by an allergenic tolerance, where the implication of T regulatory (Treg) cells is considered essential. The pollen of the olive tree is one of the most prevalent causes of respiratory allergic diseases in Mediterranean countries, inducing mainly nasal and conjunctival symptoms, although, in areas with a high antigenic load, olive-tree pollen may cause asthma exacerbation. Classically, olive-pollen allergy treatment has been based on specific immunotherapy using whole-olive pollen extracts. Despite extracts standardization, the effectiveness of this strategy varies widely, therefore there is a need for more effective AIT approaches. One of the most attractive is the use of synthetic peptides representing the B- or T-cell epitopes of the main allergens. This review summarizes experimental evidence of several T-cell epitopes derived from the Ole e 1 sequence to modulate the response to olive pollen in vitro, associated with several possible mechanisms that these peptides could be inducing, showing their usefulness as a safe preventive tool for these complex diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing.
- Author
-
Pozo, Victoria Del, de Andrés, Belen, Martín, Elena, Cárdaba, Blanca, Fernández, Julio Cesar, Gallardo, Soledad, Tramón, Paloma, Palomino, Pilar, Lahoz, Carlos, and Leyva-Cobian, Francisco
- Published
- 1992
- Full Text
- View/download PDF
17. Ole e I: Epitope Mapping, Cross-Reactivity with Other Oleaceae Pollens and Ultrastructural Localization.
- Author
-
Martín-Orozco, Elena, Cárdaba, Blanca, del Pozo, Victoria, de Andrés, Belén, Villalba, Mayte, Gallardo, Soledad, Rodriguez-García, Maria Isabel, Fernández, Mari Carmen, Alché, Juan D., Rodriguez, Rosalia, Palomino, Pilar, and Lahoz, Carlos
- Published
- 1994
- Full Text
- View/download PDF
18. Therapeutic potential of peptides from Ole e 1 in olive-pollen allergy.
- Author
-
Calzada, David, Cremades-Jimeno, Lucía, Pedro, María Ángeles de, Baos, Selene, Rial, Manuel, Sastre, Joaquín, Quiralte, Joaquín, Florido, Fernando, Lahoz, Carlos, and Cárdaba, Blanca
- Subjects
PEPTIDES ,HAY fever treatment ,RESPIRATORY allergy ,IMMUNOTHERAPY ,ALLERGENS ,ALLERGENIC extracts - Abstract
Olive-pollen allergy is one of the leading causes of respiratory allergy in Mediterranean countries and some areas of North America. Currently, allergen-specific immunotherapy is the only etiophatogenic treatment. However, this approach is not fully optimal, safe, or effective. Thus, efforts continue in the search for novel immunotherapy strategies, being one of the most promising the use of peptides derived from major allergens. This work tries to determine the therapeutic potential and safety of 5 dodecapeptides derived from the main allergen of olive-pollen allergy, Ole e 1. The immunomodulatory capacity of these peptides was studied using peripheral blood mononuclear cells (PBMCs) obtained from 19 olive-pollen-allergic patients and 10 healthy controls. We determined the capacity of these peptides to inhibit the proliferative response toward olive-pollen allergenic extract and to induce the regulatory cytokines, IL-10 and IL-35. To test the safety and absence of allergenicity of the peptides, the basophil activation was analyzed by flow-cytometry, using peripheral blood. The results showed that two of five peptides inhibited near to 30% the proliferative response against the total olive-pollen allergenic extract in olive-pollen-allergic patients. Inhibition increased to nearly 35% when the 5 peptides were used in combination. In both cases, a statistically significant induction of IL-10 and IL-35 secretion was observed in the supernatants of allergic patients PBMCs cultures. None of the 5 peptides induced basophil activation and cross-link inflammatory cell-bound IgE. In conclusion, these results open up new possibilities in the treatment of olive-pollen allergy, which could solve some of the problems facing current therapy approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
19. Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease.
- Author
-
López-Cacho, José Manuel, Gallardo, Soledad, Posada, Manuel, Aguerri, Miriam, Calzada, David, Mayayo, Teodoro, González-Rodríguez, María Luisa, Rabasco, Antonio María, Lahoz, Carlos, and Cárdaba, Blanca
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.